Mark Lebwohl Selected Research

Tacrolimus (Prograf)

6/2020	Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
9/2009	Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
9/2005	Proven efficacy of tacrolimus for facial and intertriginous psoriasis.
5/2005	Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies.
11/2004	Tacrolimus ointment is effective for facial and intertriginous psoriasis.
4/2004	Tacrolimus ointment in the treatment of eyelid dermatitis.
7/2003	Potential future dermatological indications for tacrolimus ointment.
4/2003	Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
4/2003	Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Lebwohl Research Topics

Disease

177	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 05/2002
18	Psoriatic Arthritis 03/2024 - 10/2007
16	Neoplasms (Cancer) 03/2024 - 03/2004
16	Atopic Dermatitis (Atopic Eczema) 10/2023 - 04/2003
12	Skin Diseases (Skin Disease) 10/2023 - 06/2003
11	Actinic Keratosis 05/2024 - 10/2002
10	Infections 03/2024 - 06/2003
10	Pruritus (Itching) 10/2023 - 10/2007
10	Vitiligo 12/2022 - 07/2004
8	Pain (Aches) 05/2024 - 07/2015
8	Acne Vulgaris 03/2024 - 04/2002
7	Atrophy 12/2018 - 04/2003
6	Erythema 05/2024 - 02/2002
6	Inflammation (Inflammations) 10/2023 - 10/2002
6	Skin Neoplasms (Skin Cancer) 08/2023 - 05/2004
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 02/2002
6	Rheumatoid Arthritis 04/2017 - 07/2003
5	Headache (Headaches) 01/2023 - 08/2017
4	Herpes Zoster 03/2024 - 10/2007
4	Nasopharyngitis 10/2022 - 01/2016
4	Body Weight (Weight, Body) 05/2022 - 11/2003
4	Diarrhea 02/2021 - 08/2017
4	Nausea 02/2021 - 08/2017
4	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 11/2019 - 11/2003
4	Carcinogenesis 08/2006 - 02/2002
3	Ankylosing Spondylitis 02/2024 - 04/2017
3	Necrosis 01/2023 - 11/2011
3	Fatigue 02/2021 - 01/2019
3	COVID-19 01/2021 - 01/2020
3	Vomiting 07/2020 - 08/2017
3	Crohn Disease (Crohn's Disease) 01/2018 - 04/2010
3	Rosacea (Acne Rosacea) 01/2018 - 07/2003
2	Non-Radiographic Axial Spondyloarthritis 02/2024 - 04/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 08/2021

Drug/Important Bio-Agent (IBA)

19	Ointments (Pastes)IBA 05/2024 - 11/2002
19	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 05/2002
18	secukinumabIBA 10/2023 - 09/2013
18	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 05/2008
17	calcipotriene (calcipotriol)FDA LinkGeneric 10/2023 - 11/2002
16	Interleukin-17 (Interleukin 17)IBA 03/2024 - 07/2014
15	Monoclonal AntibodiesIBA 02/2024 - 11/2002
15	Etanercept (Enbrel)FDA Link 05/2022 - 07/2005
14	brodalumabIBA 01/2023 - 10/2015
11	Immunoglobulin A (IgA)IBA 05/2024 - 03/2016
11	InterleukinsIBA 03/2024 - 05/2008
11	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 05/2021 - 01/2013
11	SteroidsIBA 04/2021 - 07/2003
10	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2005
9	bimekizumabIBA 04/2024 - 01/2021
9	ixekizumabIBA 02/2024 - 12/2014
9	Adalimumab (Humira)FDA Link 01/2023 - 03/2008
9	Tacrolimus (Prograf)FDA LinkGeneric 06/2020 - 04/2003
8	CytokinesIBA 03/2022 - 11/2004
8	Alefacept (Amevive)FDA Link 03/2010 - 03/2003
7	Interleukin-23 (Interleukin 23)IBA 09/2023 - 04/2010
7	Tumor Necrosis Factor InhibitorsIBA 09/2018 - 07/2005
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2018 - 03/2004
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
6	apremilastIBA 03/2024 - 08/2017
6	halobetasol (ulobetasol)FDA LinkGeneric 12/2018 - 11/2002
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018 - 10/2007
6	AerosolsIBA 06/2017 - 02/2016
5	Infliximab (Remicade)FDA Link 12/2018 - 01/2008
5	tazarotene (Tazorac)FDA Link 12/2018 - 04/2002
5	RetinoidsIBA 01/2018 - 09/2002
5	3-ingenyl angelateIBA 02/2017 - 03/2012
5	Ficusin (Psoralen)IBA 06/2009 - 02/2002
5	efalizumab (Raptiva)FDA Link 06/2009 - 11/2003
5	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 06/2008 - 05/2002
5	Acitretin FDA Link 05/2008 - 09/2002
4	risankizumabIBA 05/2024 - 01/2018
4	Prostaglandins AIBA 12/2023 - 04/2004
4	guselkumabIBA 09/2023 - 01/2018
4	Certolizumab Pegol FDA Link 06/2023 - 01/2009
4	Interleukin-17 ReceptorsIBA 01/2023 - 02/2021
4	Interleukin-12 (IL 12)IBA 06/2018 - 02/2007
4	afamelanotideIBA 07/2015 - 01/2013
4	Calcitriol (Calcijex)FDA LinkGeneric 02/2012 - 09/2003
4	pimecrolimus (Elidel)FDA Link 07/2011 - 11/2004
3	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2024 - 12/2023
3	deucravacitinibIBA 03/2024 - 12/2023
3	difelikefalinIBA 10/2023 - 01/2023
3	Vitamin D FDA LinkGeneric 08/2023 - 09/2003
3	ruxolitinibIBA 10/2022 - 11/2020
3	FumaratesIBA 01/2022 - 09/2009
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2020 - 06/2009
3	Imiquimod (Aldara)FDA LinkGeneric 01/2009 - 10/2002
3	Benzo(a)pyreneIBA 03/2008 - 04/2003
3	IsoflavonesIBA 08/2006 - 02/2002
3	GenisteinIBA 08/2006 - 02/2002
2	Alanine Transaminase (SGPT)IBA 04/2024 - 11/2023
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024 - 11/2023
2	Immunomodulating AgentsIBA 03/2024 - 01/2018
2	Bexarotene (LGD1069)FDA Link 11/2023 - 09/2002
2	Janus KinasesIBA 10/2023 - 07/2020

Therapy/Procedure

79	Therapeutics 03/2024 - 04/2002
20	Biological Therapy 01/2023 - 04/2003
14	Phototherapy (Light Therapy) 12/2022 - 06/2006
5	Excimer Lasers 09/2019 - 07/2004
2	Complementary Therapies (Alternative Medicine) 10/2023 - 02/2021